It’s incredibly difficult to measure the size of the life ILS market in terms of assets under management held by investment funds. There’s little publicly available data, and naturally, many asset managers won’t provide information unless they’re forced to. So, we wanted to ask our readers what they thought, with a little bit of educated guessing on our part. We offered three…
Insurers are favouring funded re as it helps firms manage the market and longevity risks associated with writing bulk purchase annuity (BPA) business by reducing capital charges and therefore making PRT deals more competitive.
Unsurprisingly, given its growth and potential for capital optimisation, UK regulators have been carefully watching the increased use of funded re. In June 2023, the Prudential Regulatory Authority (PRA) sent a “Dear CRO’ letter to heads of risk at UK life insurers.
The letter outlined the regulator’s two main concerns from a sectoral review which it had carried out.
“One of the key risks arising in funded re is that firms recapture sub-optimal portfolios with depressed values and with limited ability to be transformed effectively to the firms’ preferred portfolio,” the PRA letter said.
Post a comment
Related Posts
Significant Growth Potential in Equity Release/Reverse Mortgage Market but Change is Required to Get There
The global equity release/reverse mortgage market could be worth $56bn by 2035, according to a…
Insurance Capacity Boost and Growth in Small Deals Mark Busy First Half in UK Pension Risk Transfer Market
The UK’s bulk purchase annuity (BPA) market has been marked this year by the intensification…
Life Settlement Population Outlook Suggests Underwriting Frameworks Will Need to Continue to Adjust
According to a recent article in InsuranceNewsNet, The Life Mortality Improvement Subgroup of the Society…
Mental Health Illness and Its Impact on Life Expectancy in the USA
A mental disorder is characterized by a clinically significant disturbance in an individual’s cognition, emotional…
